Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Recurrence × Cisplatin × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Uterine Cervical Neoplasms 2 Urothelial Cancer 2 Urinary Bladder Neoplasms 2 Mesothelioma 2 Head and Neck Neoplasms 2 Carcinoma 2 Various Advanced Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Ototoxicity 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Liver Neoplasms 1 Hepatoblastoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Bile Duct Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

tisagenlecleucel 2 blinatumomab 2 zanubrutinib 1 selinexor 1 revumenib 1 niraparib 1 nilotinib 1 ivosidenib 1 imetelstat 1 idecabtagene vicleucel 1 ibrutinib 1 fludarabine 1 entrectinib 1 dostarlimab 1 avapritinib 1 asciminib 1 Standard of Care 1 Paclitaxel 1 Imatinib Mesylate 1 GRN163L peptide 1 Drug Therapy 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡